Structurally different anthracyclines provoke different effects on cell cycle and tumor B cell differentiation

Biomedicine and Pharmacotherapy

Volumn 52, Issue 6, 1998, Pages 282-290

  Teillaud, J L ^a   Gruel, N ^a   Moncuit, J ^a   Mishal, Z ^b   Fridman, W H ^a   Lampidis, T J ^c   Tapiero, H ^d  

^a INSTITUT CURIE   (France)

^b HÔPITAL PAUL BROUSSE   (France)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d UNIV PARIS SUD   (France)

Author keywords

Aclarubicin; B cell; Differentiation; Doxorubicin; Immuno globulin

Indexed keywords

ACLARUBICIN; ANTHRACYCLINE DERIVATIVE; DOXORUBICIN; IMMUNOGLOBULIN G; PIRARUBICIN;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CELL CYCLE; CYTOSTASIS; DRUG EFFECT; IMMUNOGLOBULIN PRODUCTION; LYMPHOCYTE DIFFERENTIATION; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

EID: 0032125631     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0753-3322(98)80014-0     Document Type: Article

References (29)

1. 1 Amigorena S, Moncuit J, Fridman WH, Teillaud J-L. A sensitive method for testing the effect of immunoglobulin-binding factor on Ig secretion by hybridoma B cells. J Immunol Methods 1987 ; 99 : 57-64
2. 2 Aquino A, Warren BS, Omichinski J, Hartman KD, Glazer RI. Protein Kinase C is present in adriamycin resistant HL-60. Biochem Biophys Res Comm 1990 ; 166 : 723-8
3. 3 Auffray C, Nageotte R, Chambraud B, Rougeon F. Mouse immunoglobulin genes: a bacterial plasmid containing the entire coding sequence for a pre-γ2a heavy chain. Nucl Acid Res 1980 ; 8 : 1231-41
4. 4 Bachur NR, Gordon SL, Gee MV, Kon H. NADPH cytochrom P-450 reductase activation of quinone anticancer agents to free radicals. Proc Nad Acad Sci USA 1979 ; 76 : 954-7
5. 5 Brunati S, Miossec C, Mathiot C et al. Regulatory effects of IgG-BF on hybridoma B cells. Molecular characterization of variant cell lines. Mol Immunol 1988 ; 11 : 1133-42
6. 6 Casazza AM. Anthracyclines as inducers of tumor cell differentiation. In: Lown JW, ed. Bioactive Molecules, vol 6. Amsterdam: Elsevier Science Publishers; 1988. p 715-34
7. 7 Cheley S, Anderson R. Reproducible microanalytical methods for the detection of specific RNA sequences by dot-blot hybridization. Anal Biochem 1984 ; 137 : 15-19
8. 8 Dubois G, Tapiero H. Variation of choline-substituted lipid metabolism in doxorubicin-resistant leukemia cells. Biomed Pharmacother 1992 ; 46 : 343-51
9. 9 Hassmann M, Valet GK, Tapiero H, Trevorrow K, Lampidis TJ. Membrane potential differences between Adriamycin sensitive and resistant cells as measured by flow cytometry. Biochem Pharmacol 1989 ; 38 : 305-12
10. 10 Horichi N, Tapiero H, Sugimoto Y et al. MX2 3′-Deamino-3′-Morpholino-13-Deoxo-10-Hydroxycarminomycin conquers multidrug resistance by rapid influx following higher frequency of formation of DNA single and double strand breaks. Cancer Res 1990 ; 50 : 4698-701
11. 11 Lampidis TJ, Kolonias D, Podona T et al. Circumvention of P-GP MDR as a function of anthracycline lipophilicity and charge. Biochemistry 1997 ; 36 : 2679-85
12. 12 Lee SA, Karaszkiewicz JW, Anderson WB. Elevated level of nuclear protein kinase C in multidrug resistant MCF-7 human breast carcinoma cell. Cancer Res 1992 ; 52 : 3750-9
13. 13 Liu LF. DNA topoisomerase poisons as antitumor drugs. Ann Rev Biochem 1989 ; 58 : 351-75
14. 14 Mazouzi Z, Francastel C, Tapiero H, Robert-Lèzénès J. Growth inhibition of doxorubicin-resistant K562 leukemia cells by anthracyclines: absence of correlation with erythroid differentiation. J Cell Pharmacol 1991 ; 2 : 157-64
15. 15 Morceau F, Chénais B, Gillet R, Jardiller JC, Jeannesson P, Trentseaux C. Transcriptional and posttranscriptional regulation of erythroid gene expression in anthracycline-induced differentiation of human erythroleukemic cells. Cell Growth Differ 1996 ; 7 : 1023-9
16. 16 Nishiyama M, Horichi H, Mazouzi Z, Bungo M, Saijo N, Tapiero H. Can cytotoxic activity of anthracyclines be related to DNA damage? Anti-Cancer Drug Design 1990 ; 5 : 135-9
17. 17 O'Brian CA, Fan D, Ward NE, Scid C, Fidler IJ. Level of protein kinase C activity correlates with drug resistance to adriamycin in murine fibrosarcoma cells. FEBS Lett 1989 ; 246 : 78-82
18. 18 Pommier Y, Schwartz RE, Zwelling LA, Kohn KW. Effects of DNA intercalating agents on topoisomerase II induced DNA strand cleavage in isolated mammalian cell nuclei. Biochem 1985 ; 24 : 6406-10
19. 19 Posada JA, Vichi P, Tritton TR. Protein kinase C in adriamycin action and resistance in mouse S180 cells. Cancer Res 1989 ; 49 : 6634-9
20. 20 Ralph P, Nakoinz I, Diamond B, Yelton D. All classes of murine IgG antibody mediate macrophage phagocytosis and lysis of erythrocytes. J Immunol 1980 ; 25 : 1885-8
21. 21 Ross W. DNA topoisomerases as targets for cancer therapy. Biochem Pharmacol 1985 ; 34 : 4191-5
22. 22 Tapiero H, Mishal Z, Wioland M, Silber A, Fourcade A, Zwingelstein G. Changes in biophysical parameters and in phosphotipid composition associated with resistance to doxorubicin. Anticancer Res 1986 ; 6 : 649-52
23. 23 Tapiero H. Cellular Response to Pirarubicin. In: Jacquillat C, Weil M, Khayat D, eds. Neo-Adjuvant Chemotherapy, vol 169. London: John Libbey Eurotext Ltd; 1988. p 811-12
24. 24 Tapiero H, Horichi N, Nishiyama M et al. Molecular basis for selectivity and effects of anthracyclines. In: Mihich E, ed. Drug resistance: mechanisms and reversal. Milan: John Libbey-CIC Publishers; 1990. p. 233-50
25. 25 Teillaud J-L, Fourcade A, Huppert J, Fridman WH, Tapiero H. Effects of doxorubicin on mouse hybridoma B cells: stimulation of immunoglobulin synthesis and secretion. Cancer Res 1989 ; 49 : 5123-9
26. 26 Tewey KM, Rowe TC, Yang L, Halligan BD, Liu LF. ADR-induced DNA damage mediated by mammalian DNA Topo II. Science 1984 ; 226 : 466-8
27. 27 Thibaut E, Amigorena S, Moncuit J, Fridman WH, Teillaud J-L. Software for the quantitative evaluation of in vitro monoclonal antibody production from ELISA data. J Immunol Methods 1987 ; 104 : 15-24
28. 28 Traganos F, Staiano-Coico L, Darzynkiewicz Z, Melamed MR. Effects of aclacinomycin on cell survival and cell cycle progression of cultured mammalian cells. Cancer Res 1981 ; 41 : 2728-37
29. 29 Tritton TR. Cell surface actions of anthracyclines. Pharmacol Ther 1991 ; 49 : 293-309